Western blot Antibody Troubleshooting guide

 

 

Problem 1: No bands observed

 

°¡´ÉÇÑ ¿øÀÎ

ÇØ°á ¹æ¹ý

Insufficient antibody

Ø Target protein¿¡ Ç×üÀÇ affinity°¡ ³·Àº °ÍÀÌ ¿øÀÎÀÏ ¼ö ÀÖÀ¸¹Ç·Î, Ç×üÀÇ Àû¿ë ³óµµ¸¦ ³ô¿©º¼ °Í (Ãßõ ½ÃÀÛ ³óµµº¸´Ù 2~4¹è ³ô°Ô)

Ø Ç×ü°¡ È°¼ºÀ» ÀÒÀº °æ¿ì, Dot blotÀ» ÇØ º¼ °Í.

Insufficient protein

Ø Á©¿¡ ·ÎµùÇÏ´Â proteinÀÇ ¾çÀ» ´Ã·Áº¼ °Í.

Ø ´Ù¸¥ ¹æ¹ýÀ¸·Î proteinÀÇ ³óµµ ÃøÁ¤À» ÇØ º¼ °Í

Ø Positive controlÀ» »ç¿ëÇÒ °Í (recombinant protein, cell line or treat cells to express analyte of interest).

Ø Dot blotÀ» ÇØ º¼ °Í.

Poor transfer

Ø  PVDF/Immobilon-P membraneÀº methanolÀ̳ª, nitrocellulose membraneÀº transfer buffer¿¡ Àû½Ç °Í.

Incomplete transfer

Ø  Transfer ½Ã°£À» Á¶Àý ÇØ º¼ °Í. ÀϹÝÀûÀ¸·Î MW°¡ Å« proteinÀº Á» ´õ ±ä transfer½Ã°£ÀÌ ÇÊ¿äÇÏ´Ù.

Ø  Transfer°¡ ¿Ï·áµÈ °ÍÀ» È®ÀÎÇϱâ À§Çؼ­, memb.À» Ponceau S, Amino Black³ª India Ink·Î ¿°»öÇØ º¼ °Í.

Ø  Pre-stained MW markerÀ» »ç¿ëÇØ º¼ °Í

(R&D systems cat.#MW002)

Over transfer

Ø ProteinÀÇ MWÀÌ 10kDaÀÌÇÏÀÏ °æ¿ì, Voltage³ª transfer ½Ã°£À» ÁÙ¿© º¼ °Í.

Isoelectric Point°¡ 9ÀÌ»ó

Ø CAPS(pH10.5)°ú °°Àº pH°¡ ³ôÀº ¹öÆÛ¸¦ ÀÌ¿ëÇØ º¼ °Í

2° Ç×ü ¼±Åà ¿À·ù

Ø 1°Ç×üÀÇ host species¿Í Ig typeÀ» È®ÀÎ ÇØ º¼ °Í.

¿À·¡µÈ Ç×ü

Ø ¸¸¾à Ç×üÀÇ À¯È¿±â°£ÀÌ ¸¸·áµÇ°Å³ª, º¸Áõ ±â°£ÀÌ Áö³­ °æ¿ì, »õ Ç×ü¸¦ ±¸ÀÔÇÏ¿© »ç¿ëÇÒ °Í.

Ç×üÀÇ º¸°ü ¿À·ù

Ø Á¦Á¶»ç°¡ ±Ç°íÇÏ´Â ÀúÀå Á¶°ÇÀ» µû¸£°í, freeze/thaw cyclesÀ» ÇÇÇÒ °Í.

Sodium Azide ¿À¿°

Ø HRP signalÀ» ¾àÈ­½Ãų ¼ö ÀÖ´Â Sodium AzideÀÌ Ã·°¡µÇÁö ¾ÊÀº ¹öÆÛ¸¦ »ç¿ë ÇÒ °Í.

ºÒÃæºÐÇÑ 1°Ç×ü ¹ÝÀÀ

Ø 4°C¿¡¼­ overnight

 

Problem2: Faint Bands (Weak Signal)

 

°¡´ÉÇÑ ¿øÀÎ

ÇØ°á ¹æ¹ý

Low protein-antibody binding

Ø  Washing Ƚ¼ö¸¦ ÃÖ¼ÒÈ­ ÇÒ °Í.

Ø  Wash buffer¿¡ NaCl ³óµµ¸¦ ÁÙ¿© º¼ °Í (0.15M~0.5M).

Ø  Antibody solutiomÀÇ NaCl ³óµµ¸¦ ÁÙ¿© º¼ °Í(0.15M~0.5M).

Insufficient antibody

Ø Target protein¿¡ Ç×üÀÇ affinity°¡ ³·Àº °ÍÀÌ ¿øÀÎÀÏ ¼ö ÀÖÀ¸¹Ç·Î, Ç×üÀÇ Àû¿ë ³óµµ¸¦ ³ô¿©º¼ °Í

 (Ãßõ ½ÃÀÛ ³óµµº¸´Ù 2~4¹è ³ô°Ô)

Insufficient protein

Ø Á©¿¡ ·ÎµùÇÏ´Â proteinÀÇ ¾çÀ» ´Ã·Áº¼ °Í.

Inactive conjugate

Ø Enzyme°ú substrateÀ» ¼¯¾î¼­ ¹ß»ö¹ÝÀÀÀ» È®ÀÎ ÇØ º¼ °Í.

¸¸¾à ¹ß»öµÇÁö ¾Ê°Å³ª ¹ß»ö Á¤µµ°¡ ¾àÇÏ´Ù¸é »õ·Î¿î reagentsÀ» ±¸ÀÔÇÒ °Í. ECLÀ» ¹Ù²ð °Í.

Weak/Old ECL

Ø »õ·Î¿î Enhanced Chemiluminescence(ECL)±¸ÀÔÇÒ °Í.

Non-fat dry milk

Ø Blocking/ antibody solutionÀÇ not-fat dry milk ³óµµ¸¦ ÁÙÀ̰ųª, 3% BSA·Î ´ëüÇØ º¼ °Í.

 

Problem3: Extra Bands

°¡´ÉÇÑ ¿øÀÎ

ÇØ°á ¹æ¹ý

1° Ç×üÀÇ ºñƯÀÌÀû ¹ÝÀÀ

Ø Á©¿¡ ·ÎµùÇÏ´Â proteinÀÇ ¾çÀ» ÁÙ¿© º¼ °Í

Ø MonoclonalÀ̳ª antigen affinity purified antibodiesÀ» »ç¿ëÇÒ °Í

Ø 1 ° Ç×üÀÇ ³óµµ¸¦ ÁÙ¿© º¼ °Í

http://www.rndsystems.com/dam_public/5876.jpg

Bolded concentrations indicate he reduction of the primary antibody concentration.

A.       Blocked in 5% milk,

1.0 microgram/mL primary antibody in 5% milk and 0.15 M NaCl.

B.       Blocked in 5% milk,

0.2 microgram/mL primary antibody in 5% milk and 0.15 M NaCl

2° Ç×üÀÇ ºñƯÀÌÀû ¹ÝÀÀ

Ø 1° Ç×ü¸¦ Á¦¿ÜÇÏ°í 2°Ç×ü¸¸ control·Î ½ÇÇèÇØ º¼ °Í.

( control test °á°ú band°¡ º¸À̸é, ´Ù¸¥ 2° Ç×ü¸¦ »ç¿ëÇÒ °Í)

Ø MonoclonalÀ̳ª antigen affinity purified antibodiesÀ» »ç¿ëÇÒ °Í (Cat.# BAFxx, HAFxx)

1°Ç×ü³ª 2°Ç×üÀÇ ºñ ƯÀÌÀû ¹ÝÀÀ

Ø Antibody solution¿¡ 0.1~0.5% TweenÒ20À» ÷°¡ÇØ º¼ °Í.

Ø Washing Ƚ¼ö¸¦ ´Ã·Á º¼ °Í.

Ø Wash buffer¿¡ 0.1~0.5% TweenÒ20À» ÷°¡ÇØ º¼

Ø 1°Ç×ü¿Í 2°Ç×ü¸¦ Èñ¼®ÇÒ ¶§ blotting buffer¿¡ 2% non-fat dry milkÀ» ÷°¡ÇÏ¿© »ç¿ëÇÒ °Í. Ç×ü Àû¿ë ³óµµ¸¦ ÇÊ¿ä¿¡ µû¶ó Á¶Á¤ÇÒ °Í.

Ø Antibody dilution¿Í Wash step¿¡¼­ »ç¿ëµÇ´Â buffer¿¡ NaCl³óµµ¸¦ ³ô¿© º¼ °Í (Ãßõ ³óµµ0.15M~0.5M)

 

 

Figure 2a – Effect of Varying Primary Antibody Concentration in Antibody Solution with 2% Milk:

 

Bolded concentrations indicate the dilution of the primary antibody concentration.

A.    Blocked in 5% milk, 1.0 microgram/mL primary antibody in 2% milk and 0.15 M NaCl.

B.    Blocked in 5% milk, 0.3 microgram/mL primary antibody in 2% milk and 0.15 M NaCl.

C.    Blocked in 5% milk, 0.1 microgram/mL primary antibody in 2% milk and 0.15 M NaCl.

 

 

 

 

http://www.rndsystems.com/dam_public/5878.jpgFigure 2b – Effect of Varying Primary Antibody Concentration in Antibody Solution with 5% Milk:

 

 

 

 

 

 

 

In addition to the dilution of the primary antibody concentration (bolded), the milk concentration in the Antibody Solution was also increased.

D.   Blocked in 5% milk, 1.0 microgram/mL primary antibody in 5% milk and 0.15 M NaCl.

E.    Blocked in 5% milk, 0.3 microgram/mL primary antibody in 5% milk and 0.15 M NaCl.

F.    Blocked in 5% milk, 0.1 microgram/mL primary antibody in 5% milk and 0.15 M NaCl.

http://www.rndsystems.com/dam_public/5879.jpgFigure 2c – Effect of Varying NaCl Concentration in Blotting Buffer:

 

 

 

 

 

 

 

Bolded concentrations indicate the increased NaCl concentrations in the Blotting Buffer.

G.  Blocked in 5% milk, 1.0 microgram/mL primary antibody in 5% milk and 0.15 M NaCl.

H.   Blocked in 5% milk, 1.0 microgram/mL primary antibody in 5% milk and 0.5 M NaCl.

Aggregation of analyte

Ø  Disulfide bondsÀÇ reductionÀ» À§ÇØ ÃæºÐÇÑ DTTÀ» ÷°¡ÇÒ °Í

(Ãßõ ³óµµ 20~100mM). gel¿¡ loading Çϱâ Àü 5-10ºÐ µ¿¾È water bath¿¡¼­ heatingÇØ ÁÙ °Í.

Degradation of Analyte

Ø  Brief centrifugationÀ» ÇÒ °Í.

Ø  »ùÇÃÀÇ Freeze/thaw cyclesÀ» ÃÖ¼ÒÈ­ÇÒ °Í.

Ø  »ùÇà ÀúÀå Àü¿¡ protease inhibitorsÀ» ÷°¡ ÇÒ °Í.

Ø  Fresh sampleÀ» »ç¿ëÇÒ °Í.

Reagents ¿À¿°

Ø ¹Ì¸³ÀÚ³ª ¹ÚÅ׸®¾Æ·Î ÀÎÇÑ ¹öÆÛ ¿À¿°¿¡ ÀÖ´ÂÁö È®ÀÎ ÇÒ °Í.

Ø Fresh ReagentsÀ» ¸¸µé¾î »ç¿ëÇÒ °Í.

 

Problem4: High Background

 

°¡´ÉÇÑ ¿øÀÎ

ÇØ°á ¹æ¹ý

Insufficient blocking

Ø Start with 5% dry milk with 0.1~0.5% Tween 20, 0.15~0.5MÀÇ NaCl in 25mM Tris(pH7.4). ¹ÝÀÀ ½Ã°£À» ´Ã·Áº¸°í, milk ³óµµ¸¦ Á¶Á¤ÇØ º¼ °Í.

Ø Detergents°¡ ³·Àº ¿Âµµ¿¡¼­ È¿°úÀûÀÌÁö ¾ÊÀ» ¼ö ÀÖ¾î, 4°C¿¡¼­ overnight ¹ÝÀÀ¿¡¼­ blocking efficiency°¡ ¶³¾îÁú ¼ö ÀÖ´Ù.

Non-fat dry milk°¡ target antigenÀ» Æ÷ÇÔÇÏ´Â °æ¿ì

Ø 3% BSA·Î ±³Ã¼ÇÒ °Í.

Non-fat dry milk°¡ endogenous biotinÀ» Æ÷ÇÔÇÏ°í ÀÖ¾î Avidin/streptavidin complexÇü¼º¿¡ ¿µÇâ

Ø 3% BSA·Î ±³Ã¼ÇÒ °Í.

ÀϺΠIgY Ç×ü°¡ milk proteinÀ» ÀνÄ

Ø 3% BSA·Î ±³Ã¼ÇÒ °Í.

1° Ç×üÀÇ ºñƯÀÌÀû ¹ÝÀÀ

Ø MonoclonalÀ̳ª antigen affinity purified antibodiesÀ» »ç¿ëÇÒ °Í

Ø 5% milk blocking buffer »ç¿ë.

1°Ç×ü solutionÀÇ Milk ³óµµ(2~5%)³ª NaCl³óµµ(0.15~0.5M)¸¦ Á¶Á¤ÇØ º¼ °Í.

 

Figure 3 Effect of Varying Milk and NaCl Concentrations:

 

http://www.rndsystems.com/dam_public/5880.jpgBolded concentrations indicate adjustments in the milk and NaCl concentrations.

A.    Blocked in 5% milk, 1.0 microgram/mL primary antibody in 2% milk and 0.15 M NaCl.

B.    Blocked in 5% milk, 1.0 microgram/mL primary antibody in 5% milk and 0.15 M NaCl.

Blocked in 5% milk, 1.0 microgram/mL primary antibody in 5% milk and 0.5 M NaCl.

 

Ø 1° Ç×üÀÇ dilution/ wash buffersÀÇ NaClÀÇ ³óµµ¸¦ ³ô¿©º¼ °Í.

(Ãßõ ³óµµ 0.15~0.5M)

http://www.rndsystems.com/dam_public/5881.jpgFigure 4 Effect of Varying NaCl Concentration in Blotting Buffer:

Bolded concentrations indicate an increase in the NaCl concentration in the primary Antibody Solution.

A.            Blocked in 5% milk, 1.0 microgram/mL primary antibody in 5% milk and 0.15 M NaCl.

 

B.            Blocked in 5% milk, 1.0 microgram/mL primary antibody in 5% milk and 0.5 M NaCl.

 

 

2° Ç×üÀÇ ºñƯÀÌÀû ¹ÝÀÀ

Ø 1° Ç×ü¸¦ Á¦¿ÜÇÏ°í 2°Ç×ü¸¸ control·Î ½ÇÇèÇØ º¼ °Í.

(control test °á°ú band°¡ º¸À̸é, ´Ù¸¥ 2° Ç×ü¸¦ »ç¿ëÇÒ °Í)

Insufficient wash

Ø Wash Ƚ¼ö¸¦ ´Ã·Á º¼ °Í

Ø Wash bufferÀÇ Tween 20 (0.1~0.5%)ÀÇ ³óµµ¸¦ ³ô¿© º¼ °Í.

Film overexposed

Ø Exposure ½Ã°£À» ÁÙÀÏ °Í.

Ø Target signalÀÌ ³Ê¹« °­ÇÒ °æ¿ì, 5-10ºÐ ±â´Ù¸° ÈÄ re-exposeÇÒ °Í

 

Problem 5: Diffuse Bands

 

°¡´ÉÇÑ ¿øÀÎ

ÇØ°á ¹æ¹ý

Excessive protein on gel

Ø loadingÇÏ´Â protein¾çÀ» ÁÙÀÏ °Í.

 

Problem 6: White Bands (ECL method)

 

°¡´ÉÇÑ ¿øÀÎ

ÇØ°á ¹æ¹ý

Excessive signal generated

Ø Ç×ü³ª »ùÇÃÀÇ ³óµµ¸¦ ÁÙÀÏ °Í.

°úµµÇÑ Ç×ü³ª »ùÇþçÀº localized signal(ÁÖ·Î ½Ì±Û ¹êµå¿¡¼­)¿¡¼­ high levelÀ» À¯µµÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ °á°ú ±× ºÎÀ§¿¡¼­¸¸ substrate°¡ ºü¸£°Ô ¼ÒºñµÇ¾î ¹ÝÀÀÀÌ ¿Ï·áµÈ´Ù. ¹ÝÀÀÀÌ ¿Ï·áµÇ¸é ´õ ÀÌ»ó light productionÀÌ ¾ø±â ¶§¹®¿¡ Çʸ§¿¡ exporsure½Ãų ¶§ white band°¡ ³ªÅ¸³­´Ù.

 

Problem 7: Patch uneven spots all over the blot

 

°¡´ÉÇÑ ¿øÀÎ

ÇØ°á ¹æ¹ý

Reagents ¿À¿°

Ø ¹Ì¸³ÀÚ³ª ¹ÚÅ׸®¾Æ·Î ÀÎÇÑ ¹öÆÛ ¿À¿°¿¡ ÀÖ´ÂÁö È®ÀÎ ÇÒ °Í.

Ø Fresh ReagentsÀ» ¸¸µé¾î »ç¿ëÇÒ °Í.

Incubation/wash °úÁ¤¿¡¼­ ¹öÆÛ ºÎÁ·

Ø Incubation/wash °úÁ¤¿¡¼­ membraneÀÌ ÃæºÐÈ÷ Àá±âµµ·Ï È®ÀÎ ÇÒ °Í.

membrane»ó °ø±â¹æ¿ï

Ø °ø±â ¹æ¿ïÀ» Á¶½ÉÇؼ­ Á¦°ÅÇÑ´Ù. ƯÈ÷, transfer ´Ü°è¿¡¼­ ÁÖÀÇ!

Incubationµ¿¾È uneven agitation

Ø Rocker/shaker°¡ ³õ¿©Áø ÀÚ¸®ÀÇ Æò±ÕÀÌ ¸Âµµ·Ï È®ÀÎÇÒ °Í.

Contaminated equipment

Ø Àü±â¿µµ¿ ÀåÄ¡°¡ ±ú²ýÇÏ°Ô Àß ´Û¿´´ÂÁö È®ÀÎÇÒ °Í.

ProteinÀ̳ª gelÀÇ ÀÜ¿©¹°ÀÌ ³²¾ÆÀÖ°Ô µÇ¸é, membrane¿¡ ºÙÀ» ¼ö ÀÖ´Ù. MembraneÀ» ÃæºÐÈ÷ washingÇÒ °Í.

HRP aggregation

Ø HRP aggregatesÀ» Á¦°ÅÇϱâ À§ÇØ filteringÇÒ °Í.

Long exposure

Ø Exposure ½Ã°£À» ÁÙ¿© º¼ °Í.

Antibody Home

 

Additional Information
Q&A

Troubleshooting guide_IHC

Tech Tip